A strong recommendation to use neoadjuvant therapy more routinely was one of the key messages from the St Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer. Many of the recommendations provide the potential to de-escalate further treatment and reduce toxicities for patients. Co-author Associate Professor Prue Francis, head of medical ...
Treatment de-escalation possible in early breast cancer
By Mardi Chapman
5 Sep 2017